Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Psychol Addict Behav. 2017 Jul 17;31(5):534–547. doi: 10.1037/adb0000298

Figure 1. Reduced Stroop-related Activity at Post-Treatment vs. Beginning-of-Treatment.

Figure 1

A. Changes in Stroop effect-related activity (incongruent>congruent trials) at post-treatment versus beginning-of-treatment in the sample overall (N=26). Blue indicates regions with lower Stroop-related BOLD signal at post-treatment relative to beginning-of-treatment. fMRI results are family-wise-error-corrected for multiple comparisons at pFWE<.05. For additional details see Table 3A. For full results, see Supplementary Figure 2.

B. The mean extracted betas from significant clusters (significant clusters shown in section A, in full Supplementary Figure 2 and reported in Table 3A). Mean betas are presented for each trial type (incongruent, congruent) and time point (beginning-of-treatment, post-treatment), relative to all unmodeled baseline. L= left, R= right. Bars are in following order: Congruent (Beginning-of-Treatment), Incongruent (Beginning-of-Treatment), Congruent (Post-Treatment), Incongruent (Post-Treatment). Fill color indicates trial type (white= congruent; grey= incongruent). Border color indicates time point (black=Beginning-of-Treatment; red= Post-Treatment). Error bars represent +/− 1 SEM.